Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.

M Hänel; N Kröger; F Kroschinsky; Josef Birkmann; A Hänel; R Herbst; R Naumann; K Friedrichsen; G Ehninger; A R Zander; F Fiedler

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.

M Hänel, N Kröger, F Kroschinsky, Josef Birkmann (Co-author), A Hänel, R Herbst, R Naumann, K Friedrichsen, G Ehninger, A R Zander, F Fiedler

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	387-395
Journal	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume	127
Issue number	6
Publication status	Published - 2001

Keywords

NON-HODGKINS-LYMPHOMA
BONE-MARROW TRANSPLANTATION
SOUTHWEST-ONCOLOGY-GROUP
TERM FOLLOW-UP
MINI-BEAM
DEXA-BEAM
PROGNOSTIC FACTORS
INTENSIVE THERAPY
TUMOR-CELLS
DISEASE

Cite this

Hänel, M., Kröger, N., Kroschinsky, F., Birkmann, J., Hänel, A., Herbst, R., Naumann, R., Friedrichsen, K., Ehninger, G., Zander, A. R., & Fiedler, F. (2001). Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , 127(6), 387-395.

Hänel, M ; Kröger, N ; Kroschinsky, F et al. / Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. In: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2001 ; Vol. 127, No. 6. pp. 387-395.

@article{27fd2be53c15447e8d655c154b272cad,

title = "Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.",

keywords = "NON-HODGKINS-LYMPHOMA, BONE-MARROW TRANSPLANTATION, SOUTHWEST-ONCOLOGY-GROUP, TERM FOLLOW-UP, MINI-BEAM, DEXA-BEAM, PROGNOSTIC FACTORS, INTENSIVE THERAPY, TUMOR-CELLS, DISEASE",

author = "M H{\"a}nel and N Kr{\"o}ger and F Kroschinsky and Josef Birkmann and A H{\"a}nel and R Herbst and R Naumann and K Friedrichsen and G Ehninger and Zander, {A R} and F Fiedler",

year = "2001",

language = "English",

volume = "127",

pages = "387--395",

journal = "JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY ",

issn = "0171-5216",

number = "6",

}

Hänel, M, Kröger, N, Kroschinsky, F, Birkmann, J, Hänel, A, Herbst, R, Naumann, R, Friedrichsen, K, Ehninger, G, Zander, AR & Fiedler, F 2001, 'Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.', JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol. 127, no. 6, pp. 387-395.

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. / Hänel, M; Kröger, N; Kroschinsky, F et al.
In: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , Vol. 127, No. 6, 2001, p. 387-395.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.

AU - Hänel, M

AU - Kröger, N

AU - Kroschinsky, F

AU - Birkmann, Josef

AU - Hänel, A

AU - Herbst, R

AU - Naumann, R

AU - Friedrichsen, K

AU - Ehninger, G

AU - Zander, A R

AU - Fiedler, F

PY - 2001

Y1 - 2001

KW - NON-HODGKINS-LYMPHOMA

KW - BONE-MARROW TRANSPLANTATION

KW - SOUTHWEST-ONCOLOGY-GROUP

KW - TERM FOLLOW-UP

KW - MINI-BEAM

KW - DEXA-BEAM

KW - PROGNOSTIC FACTORS

KW - INTENSIVE THERAPY

KW - TUMOR-CELLS

KW - DISEASE

M3 - Original Article

C2 - 11414199

SN - 0171-5216

VL - 127

SP - 387

EP - 395

JO - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

JF - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

IS - 6

ER -

Hänel M, Kröger N, Kroschinsky F, Birkmann J, Hänel A, Herbst R et al. Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY . 2001;127(6):387-395.